© 2000 American Heart Association, Inc.
Molecular Medicine |
Identification of cis Elements in the Cardiac Troponin T Gene Conferring Specific Expression in Cardiac Muscle of Transgenic Mice
From the Departments of Biological Sciences (Q.W., J.J.-C.L.) and Internal Medicine (C.D.S.), University of Iowa, Iowa City, Iowa.
Correspondence to Jim Jung-Ching Lin, Department of Biological Sciences, University of Iowa, 138 Biology Building, Iowa City, IA 52242-1324. E-mail jim-lin{at}uiowa.edu
Abstract—To investigate the underlying mechanism regulating cardiac gene expression, transgenic mice carrying the rat cardiac troponin T proximal promoter (-497 bp from the transcriptional start site) fused to a LacZ or chloramphenicol acetyltransferase (CAT) reporter gene were analyzed. The LacZ expression pattern throughout development was very similar to that of the endogenous cardiac troponin T gene. Within this promoter, a high degree of sequence homology was found at 2 sites, modules D (-335 to -289 bp) and F (-249 to -209 bp). Both regions contain at least a TCTG(G/C) direct repeat and an A/T-rich site, whereas only the F module has a muscle enhancer factor 2 (MEF2)-like motif. No significant decrease in CAT transgene expression was observed when only the MEF2 core sequence was mutated. However, when the MEF2 core sequence and its flanking TCTGG site were mutated (Mut5), CAT transgene expression was significantly decreased in the heart, and ectopic expression of the transgene was also observed. When mutations were introduced into this promoter to destroy all upstream TCTG(G/C) direct repeats in the D module (MutD), CAT expression remained cardiac specific, but the expression level was dramatically decreased. Relaxation of cardiac-specific transgene expression became even more severe in transgenic mice carrying double mutations (Mut[D+5]). In addition, CAT activity in the heart was nearly abolished. These results suggest that D and F modules have an additive function in determining the level of expression in the heart and only the F module confers cardiac-specific expression.
Key Words: transgenic mice • promoter • TCTG(G/C) direct repeat • A/T-rich region • cardiac-specific gene expression
This article has been cited by other articles:
 |
|
 |
|
  E. A. Gustafson-Wagner, H. W. Sinn, Y.-L. Chen, D.-Z. Wang, R. S. Reiter, J. L.-C. Lin, B. Yang, R. A. Williamson, J. Chen, C.-I. Lin, et al. Loss of mXin{alpha}, an intercalated disk protein, results in cardiac hypertrophy and cardiomyopathy with conduction defects Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2680 - H2692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Jiao, H. Kulessa, K. Tompkins, Y. Zhou, L. Batts, H. S. Baldwin, and B. L.M. Hogan An essential role of Bmp4 in the atrioventricular septation of the mouse heart Genes & Dev., October 1, 2003; 17(19): 2362 - 2367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. WERNER, S. FESSELE, H. MAIER, and P. J. NELSON Computer modeling of promoter organization as a tool to study transcriptional coregulation FASEB J, July 1, 2003; 17(10): 1228 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jane-wit, M. Yu, A. E. Edling, S. Kataoka, J. M. Johnson, L. B. Stull, C. S. Moravec, and V. K. Tuohy A Novel Class II-Binding Motif Selects Peptides That Mediate Organ-Specific Autoimmune Disease in SWXJ, SJL/J, and SWR/J Mice J. Immunol., December 1, 2002; 169(11): 6507 - 6514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Khurana, J. F. Martin, and I. Zachary Gene Therapy for Cardiovascular Disease: A Case for Cautious Optimism Hypertension, November 1, 2001; 38(5): 1210 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Flesch On the trail of cardiac specific transcription factors Cardiovasc Res, April 1, 2001; 50(1): 3 - 6. [Full Text] [PDF]
|
|